Professor, Medicine, Vanderbilt University School of Medicine
Pulmonology
Dr. Theodore F. Reiss, MD
|
|
Give Review
Theodore Reiss practices Pulmonology. Theodore Reiss is a published MD. He has 93 papers published. The most current publication "Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma."
Publications
- Bear Cage: Mentoring Through Engagement.
- The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks.
- Airway obstruction lability helps distinguish levels of disease activity in asthma.
- The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.
- Intermittent or daily montelukast versus placebo for episodic asthma in children.
- The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
- MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.
- A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
- A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder.
- A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
- Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
- Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
- Analysis of behavior-related adverse experiences in clinical trials of montelukast.
- Reports of suicidality in clinical trials of montelukast.
- A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
- Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
- Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma.
- Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
- Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.
- Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.
- Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
- Efficacy of montelukast for treating perennial allergic rhinitis.
- Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
- Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence.
- Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
- Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
- Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
- Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
- Onset of efficacy of montelukast in seasonal allergic rhinitis.
- Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
- Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.
- A randomized controlled trial of intravenous montelukast in acute asthma.
- Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
- Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
- Variability and lack of predictive ability of asthma end-points in clinical trials.
- Safety of chewable tablets for children.
- Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
- Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-contro...
- Quality assurance of asthma clinical trials.
- Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
- Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
- Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
- Use of oral montelukast in the treatment of asthma.
- Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
- Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
- Correlation of airway obstruction and patient-reported endpoints in clinical studies.
- Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.
- Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections.
- Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.
- Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults.
- Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
- Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.
- Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
- A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
- Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Rese...
- Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
- Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
- Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
- Measurement characteristics of two asthma symptom diary scales for use in clinical trials.
- Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled cortico...
- Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
- Design of the Fracture Intervention Trial.
- Abnormal lung gallium-67 uptake preceding pulmonary physiologic impairment in an asymptomatic patient with Pneumocystis carinii pneumonia.
- Short-term exposure to 0.3 ppm nitrogen dioxide does not potentiate airway responsiveness to sulfur dioxide in asthmatic subjects.
- Collaborative science and the american thoracic society: cooperation in harmony with conflict of interest.
- Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
- The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
- Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
- Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.
- Comparisons of aprepitant and ondansetron.
- Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
- Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
- Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
- Effect of montelukast on single-dose theophylline pharmacokinetics.
- Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
- Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.
- Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation.
- Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
- What are minimal important changes for asthma measures in a clinical trial?
- Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
- Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open a...
- An oral selective M3 cholinergic receptor antagonist in COPD.
- Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
- Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
- Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
- Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.
- Pericarditis associated with Hemophilus influenzae type B pneumonia and bacteremia in two adults.
- [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-I...
- Effect of exercise, hyperpnea, and bronchoconstriction on plasma atrial natriuretic peptide.
- Asthma: current strategies for treatment.
- [Acute hepatotoxicity with intermediate-dose methotrexate in children with leukemia and non-Hodgkin''s lymphoma].
- [Frequency distribution of DNA in blood and bone marrow cells of children with acute non-lymphatic leukemia using impulse cytophotometry].
Schools
Vanderbilt University
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Education
-
UCSF -
Vanderbilt University
Helpful Reviews
Similar Doctors
|
|
Dr. Jon J. Tumen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asa C. Heflin Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin A. Ferrell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adrian A. Jarquin-Valdivia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula Watson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth Holroyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Kropski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brenda Butka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Liza M. Weavind, MB BCH
This Doctor is OpenDoctor Recommended.
|